NEW YORK, July 23 - Viaken has partnered with e-science platform provider InforSense to market and distribute their large-scale genomic analysis and drug discovery platform, the companies announced Monday.

The platform, called the Kensington Discovery Edition, was developed by Copenhagen-based InforSense as networked-based software for data mining and analysis.

Terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.